Brief: Alkem Labs Denies Claims Of Pan-D, Clavam 625 Batches Being Not-Of-Standard Quality
27/09/2024 10:00
Sept 27 (Reuters) - Alkem Laboratories Ltd ALKE.NS :
* ALKEM LABS - DENIES CLAIMS OF PAN-D, CLAVAM 625 BATCHES
BEING
NOT-OF-STANDARD QUALITY
* ALKEM LABS - ALL PRODUCTS MANUFACTURED AT OUR SITES
FOLLOW
CURRENT GOOD MANUFACTURING PRACTICES
* ALKEM LABS - SAMPLES OF PRODUCTS MENTIONED IN CDSCO LIST
ARE
SPURIOUS, NOT MANUFACTURED BY ALKEM
Source text for Eikon: ID:nBSE7nqD6X
Further company coverage: ALKE.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees